Latest news with #Haldiram's
Hans India
3 days ago
- Business
- Hans India
Temasek, others can invest more if the ecosystem is conducive
The announcement by Temasek Holdings that it intends to deploy $3 billion-4 billion annually in India is good news, especially against the backdrop of less-than-desirable foreign direct investment (FDI) that we get. Net FDI, for instance, had a steep fall of over 96 per cent, to just $353 million, in 2024-25. There was recovery too, though, as in April received net FDI of $3.95 billion, the most in 35 months. The exposure of Singapore's sovereign wealth fund to India has increased to over $50 billion, as of March this year, up from $37 billion a year earlier. In March, Temasek picked up a 10 per cent stake in Haldiram's at a valuation of around $10 billion, which was termed as a 'prized asset.' 'We've been very active in investing behind family-run businesses, we can invest across the value chain,' Vishesh Shrivastav, managing director of Temasek's India investment team, said in a media interview. Earlier, Temasek invested in many family businesses in India, such as Manipal Hospitals and Dr Agarwal's Health Care. Temasek and other investors can become more bullish about India if our policy makers get their act together. To be sure, investors are closely watching India, which is widely regarded as one of the most promising emerging markets. With a large domestic market, a young and growing population, a thriving services sector, and increasing digital penetration, India offers tremendous potential for high returns over the long term. However, this optimism is often tempered by concerns over policy inconsistency, regulatory unpredictability, and bureaucratic inefficiencies. If Indian policymakers can address these challenges with clarity, consistency, and foresight, institutional investors like Temasek may significantly ramp up their commitments. Temasek has already invested in sectors such as financial services, technology, and healthcare in India. Yet, its future decisions will be influenced by the ease with which it can navigate India's regulatory environment, repatriate profits, and find long-term policy stability. A proactive policy framework, free of sudden reversals or overregulation, would send a strong signal of reliability. For instance, India's ongoing tax disputes and retrospective taxation policies have, in the past, deterred many investors. While some steps have been taken to reverse such measures, greater transparency and policy continuity are needed to rebuild long-term trust. Additionally, infrastructure bottlenecks, delays in project clearances, and land acquisition hurdles are key concerns. If the government expedites structural reforms—such as simplifying labour laws, digitising approval processes, and strengthening contract enforcement—it would greatly enhance the investment climate. Investors are also seeking greater alignment between central and state policies, as contradictions and delays in implementation at the state level can hamper project execution. Moreover, geopolitical tensions and trade dynamics increasingly factor into capital flows. With global investors diversifying away from China, India stands to benefit—but only if it positions itself as a stable and reform-oriented alternative. Clear communication from policymakers, timely execution of flagship initiatives like Make in India and Digital India, and consistency in environmental and ESG-related norms will help boost investor confidence. Temasek and other institutional investors are not just looking for growth—they are looking for predictable, rules-based systems where they can make long-term bets without fear of regulatory shocks. If Indian policymakers can deliver on this front, India could attract not just higher investment volumes but also longer-term, strategic capital, thus driving deeper transformation across its economy.
Time of India
5 days ago
- Business
- Time of India
Temasek eyes more Indian family-run businesses after Haldiram's deal
By Dhwani Pandya Singapore's state investor Temasek is looking to invest more in Indian family-run businesses , a top executive said on Monday, months after it invested $1 billion in a popular domestic snacks company. Family businesses in India, with their multigenerational legacies, strong domestic brands and loyal customers, have become attractive for global investors in recent years. In March, Temasek bought a 10% stake in Haldiram's at a valuation of around $10 billion, with sources describing it as a "prized asset" that will help investors expand its focus on India's consumer sector. "We've been very active in investing behind family-run businesses, we can invest across the value chain," Vishesh Shrivastav, managing director of Temasek's India investment team, said in an interview at its Mumbai office. Temasek has earlier invested in many businesses in India which were once run by business families, such as Manipal Hospitals and Dr Agarwal's Health Care. In a separate factsheet, Temasek said it was "keen to partner more family-owned businesses to drive long-term value creation." It did not name any potential targets. Temasek spent $2 billion in April 2023 to raise its stake in Manipal to 59% from 18% in the biggest hospital sector deal ever in India. It later sold a minority stake to Novo Nordisk's parent Novo Holdings and Abu Dhabi's sovereign investor Mubadala, but retained majority control of the hospital chain. Asked about Manipal Hospitals possible public offering, Shrivastav said it was "an eminently listable company," without elaborating. India continues to be Temasek's best-performing market over the last decade, as it remained the world's fastest-growing major economy and the second largest IPO market in 2025. Temasek said it maintained its positive outlook for India and its 2023 goal of investing up to $10 billion in Asia's third-largest economy over a three-year horizon. Temasek invested over $3 billion in India over the past year.
Time of India
6 days ago
- Business
- Time of India
India shielded against global woes: Temasek
MUMBAI: Singapore's state-owned investor Temasek has a strong deal pipeline in India, and the firm continues to scout for opportunities in the market where the value of its portfolio has hit $50 billion (includes Singtel's stake in Airtel). Tired of too many ads? go ad free now India is fairly shielded against global geopolitical shifts and macro uncertainties on the back of robust domestic consumption, raising the firm's growth prospects in the country, Vishesh Shrivastav, MD of Temasek's India investment team, told TOI in an interview. The firm, which has earmarked investments of about $10 billion for India over three years (by an estimated 2026-27), has deployed over $6 billion from that pool and is "on track" to meet that target, said Shrivastav. "We don't see a reason to change our guidance. Geopolitics is one of the biggest risks to investments today, and our focus is to build a portfolio that is resilient - something that is less impacted by shocks and where the range of outcomes is quite narrow. India is somewhat unique in the sense that it's an economy with few dependencies on the external world. It's mostly a domestic economy, and our portfolio reflects that," Shrivastav said. India, which has delivered the best returns for Temasek over the past decade, currently makes up about 8% of its portfolio, almost double its share five years ago. Temasek's India investments span traditional and new-age companies, including Axis Bank, Haldiram's, Manipal Health Enterprises, Eternal (formerly Zomato), and Lenskart. Earlier this year, the investment firm acquired a minority 9-10% stake in Haldiram Snacks Food in a deal worth more than Rs 8,000 crore, valuing the family-owned company at $10 billion. Tired of too many ads? go ad free now Temasek said that it is "keen to partner" with more family-owned businesses to drive long-term value-creation. The broader India investment strategy will be to bet on four themes - digitisation (new-age companies/startups), consumption (businesses such as Haldiram's), increasing lifespan (healthcare), and sustainable living (spaces like EV). The playbook is in line with its global strategy but resonates very well in India, said Shrivastav. A market with young, aspirational consumers seeking to spend more, policy continuity, and a lot of "good macros" places India on a better footing, making Temasek confident about its prospects, said Shrivastav. Temasek, which largely makes direct investments in India, said that the 'permanent' nature of its capital allows it to invest across the life cycle of a company and make risky startup bets. "Our capital is not constrained by time frame. .. the best companies we were in keep compounding over many years, and we have no reason to exit them just because the fund life is over. We invested in Zomato when it was a very small company, and it was one of our best performers," Shrivastav said. Temasek said it will continue investing in startups as it gives them an "ability to see what's coming in the future". Shrivastav said that 3-4 startups (apart from Lenskart) in its portfolio are IPO ready without disclosing names.
&w=3840&q=100)
Business Standard
6 days ago
- Business
- Business Standard
Temasek looks to invest more in family-run businesses after Haldiram's deal
Singapore's state investor Temasek is looking to invest more in Indian family-run businesses, a top executive said on Monday, months after it invested $1 billion in a popular domestic snacks company. Family businesses in India, with their multigenerational legacies, strong domestic brands and loyal customers, have become attractive for global investors in recent years. In March, Temasek bought a 10% stake in Haldiram's at a valuation of around $10 billion, with sources describing it as a "prized asset" that will help investors expand its focus on India's consumer sector. "We've been very active in investing behind family-run businesses, we can invest across the value chain," Vishesh Shrivastav, managing director of Temasek's India investment team, said in an interview at its Mumbai office. Temasek has earlier invested in many businesses in India which were once run by business families, such as Manipal Hospitals and Dr Agarwal's Health Care. In a separate factsheet, Temasek said it was "keen to partner more family-owned businesses to drive long-term value creation." It did not name any potential targets. Temasek spent $2 billion in April 2023 to raise its stake in Manipal to 59% from 18% in the biggest hospital sector deal ever in India. It later sold a minority stake to Novo Nordisk's parent Novo Holdings and Abu Dhabi's sovereign investor Mubadala, but retained majority control of the hospital chain. Asked about Manipal Hospitals possible public offering, Shrivastav said it was "an eminently listable company," without elaborating. India continues to be Temasek's best-performing market over the last decade, as it remained the world's fastest-growing major economy and the second largest IPO market in 2025. Temasek said it maintained its positive outlook for India and its 2023 goal of investing up to $10 billion in Asia's third-largest economy over a three-year horizon. Temasek invested over $3 billion in India over the past year.
Time of India
6 days ago
- Business
- Time of India
Temasek eyes more Indian family-run businesses after Haldiram's deal
Academy Empower your mind, elevate your skills Singapore's state investor Temasek is looking to invest more in Indian family-run businesses , a top executive said on Monday, months after it invested $1 billion in a popular domestic snacks businesses in India, with their multigenerational legacies, strong domestic brands and loyal customers, have become attractive for global investors in recent March, Temasek bought a 10% stake in Haldiram's at a valuation of around $10 billion, with sources describing it as a "prized asset" that will help investors expand its focus on India's consumer sector."We've been very active in investing behind family-run businesses, we can invest across the value chain," Vishesh Shrivastav, managing director of Temasek's India investment team, said in an interview at its Mumbai has earlier invested in many businesses in India which were once run by business families, such as Manipal Hospitals and Dr Agarwal's Health a separate factsheet, Temasek said it was "keen to partner more family-owned businesses to drive long-term value creation ." It did not name any potential spent $2 billion in April 2023 to raise its stake in Manipal to 59% from 18% in the biggest hospital sector deal ever in India. It later sold a minority stake to Novo Nordisk's parent Novo Holdings and Abu Dhabi's sovereign investor Mubadala, but retained majority control of the hospital about Manipal Hospitals possible public offering, Shrivastav said it was "an eminently listable company," without continues to be Temasek's best-performing market over the last decade, as it remained the world's fastest-growing major economy and the second largest IPO market in said it maintained its positive outlook for India and its 2023 goal of investing up to $10 billion in Asia's third-largest economy over a three-year horizon. Temasek invested over $3 billion in India over the past year.
